#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS
proLékaře.cz / Journals / Perspectives in Surgery / 2019 - 10

Radiofrequency ablation of colorectal liver metastases

Czech version

Authors: V. Třeška 1;  J. Brůha 1;  T. Skalický 1;  V. Liška 1;  J. Fichtl 1;  H. Mírka 2;  E. Korčáková 2
Authors‘ workplace: Chirurgická klinika Fakultní nemocnice Plzeň, Lékařská fakulta v Plzni, Univerzita Karlova 1;  Klinika zobrazovacích metod, Fakultní nemocnice Plzeň, Lékařská fakulta v Plzni, Univerzita Karlova 2
Published in: Rozhl. Chir., 2019, roč. 98, č. 10, s. 399-403.
Category: Original articles

Overview

Introduction: Radical liver resection is the only method for the treatment of patients with colorectal liver metastases (CLM); however, only 20–30% of patients with CLMs can be radically treated. Radiofrequency ablation (RFA) is one of the possible methods of palliative treatment in such patients.

Methods: RFA was performed in 381 patients with CLMs between 01 Jan 2001 and 31 Dec 2018. The mean age of the patients was 65.2±8.7 years. The male to female ratio was 2:1. Open laparotomy was done in 238 (62.5%) patients and the CT-navigated transcutaneous approach was used in 143 (37.5%) patients. CLMs <5 cm (usually <3 cm) in diameter were the indication for RFA. We used RFA as the only method in 334 (87.6%) patients; RFA in combination with resection was used in 36 (9.4%), and with multi-stage resection in 11 (3%) patients. We performed RFA in a solitary CLM in 170 (44.6%) patients, and in 2−5 CLMs in 211 (55.6%) patients. We performed computed tomography in each patient 48 hours after procedure.

Results: The 30-day postoperative mortality was zero. Complications were present in 4.8% of transcutaneous and in 14.2% of open procedures, respectively, in the 30-day postoperative period. One-, 3-, 5- and 10-year overall survival rates were 94.8, 66.8, 43.9 and 16.6%, respectively, in patients undergoing RFA, and 90.6, 69.1, 52.8 and 39.2%, respectively, in patients with liver resections. Disease free survival was 63.2, 30.1, 18.4 and 13.1%, respectively, in the same patients after RFA, and 71.1, 33.3, 22.8 and 15.5%, respectively, after liver resections.

Conclusion: RFA is a palliative thermal ablation method, which is one of therapeutic options in patients with radically non-resectable CLMs. RFA is useful especially in a non-resectable, or resectable (but for the price of large liver resection) solitary CLM <3 cm in diameter and in CLM relapses. RFA is also part of multi-stage liver procedures.

Keywords:

long-term results – colorectal liver metastases – radiofrequency ablation

Sources

  1. Grundmann RT. Current state of surgical treatment of liver metastases from colorectal cancer. World J Gastrointest Surg. 2011;3:183−96. doi: 10.4240/wjgs.v3.i12.183.

  2. Chow FC, Chok KS. Colorectal liver metastases: An update on multidisciplinary approach. World J Hepatol. 2019;11:150−72. doi: 10.4254/wjh.v11.i2.150.

  3. Adam R, Kitano Y. Multidisciplinary approach of liver metastases from colorectal cancer. Ann Gastroenterol Surg. 2019;3:50−6. doi: 10.1002/ags3.12227.

  4. Viganò L, Pedicini V, Comito T, et al. Aggressive and multidisciplinary local approach to iterative recurrences of colorectal liver metastases. World J Surg. 2018;42:2651−9. doi: 10.1007/s00268-018-4525-x.

  5. Petre EN, Sofocleous C. Thermal ablation in the management of colorectal cancer patients with oligometastatic liver disease. Visc Med. 2017;33:62−8. doi: 10.1159/000454697.

  6. Elias D, Viganò L, Orsi F, et al. New perspectives in the treatment of colorectal metastases. Liver Cancer 2016;6:90−8. doi: 10.1159/000449492.

  7. Benhaim L, El Hajjam M, Malafosse R, et al. Radiofrequency ablation for colorectal cancer liver metastases initially greater than 25 mm but downsized by neo-adjuvant chemotherapy is associated with increased rate of local tumor progression. HPB (Oxford) 2018;20:76−82. doi: 10.1016/j.hpb.2017.08.023.

  8. Vavra P, Nowakova J, Ostruszka P. Colorectal cancer liver metastases: laparoscopic and open radiofrequency-assisted surgery. Wideochir Inne Tech Maloinwazyjne. 2015;10:205−12. doi: 10.5114/wiitm.2015.52082.

  9. van Amerongen MJ, Jenniskens SFM, van den Boezem PB. Radiofrequency ablation compared to surgical resection for curative treatment of patients with colorectal liver metastases – a meta-analysis. HPB (Oxford) 2017;19:749−56. doi: 10.1016/j.hpb.2017.05.011.

  10. Shady W, Petre EN, Do KG. Percutaneous microwave versus radiofrequency ablation of colorectal liver metastases: Ablation with clear margins (A0) provides the best local tumor control. J Vasc Interv Radiol. 2018;29:268−75. doi: 10.1016/j.jvir.2017.08.021.

  11. Lee BC, Lee HG, Park IJ. The role of radiofrequency ablation for treatment of metachronous isolated hepatic metastasis from colorectal cancer. Medicine (Baltimore) 2016;95:e4999. doi: 10.1097/MD.0000000000004999.

  12. Dervenis C, Xynos E, Sotiropoulos G, et al. Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO). Ann Gastroenterol. 2016;29:390−416. doi 10.20524/aog.2016.0050.

  13. Hof J, Joosten HJ, Havenga K, et al. Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer. PLoS One. 2018;13:e0193385. doi: 10.1371/journal.pone.0193385.

  14. Brůha J, Liška V, Pálek R, et al. Porovnání perkutánního a otevřeného přístupu RFA u jaterních metastáz kolorektálního karcinomu. Rozhl Chir 2016;95:107−11.

  15. Třeška V, Skalický T, Ferda J, et al. Chi­rurgie jaterních metastáz kolorektálního karcinomu – přítomnost a budoucnost. Rozhl Chir 2014;93:568−71.

  16. Shady W, Petre EN, Vakiani E, et al. Kras mutation is a marker of worse oncologic outcomes after percutaneous radiofrequency ablation of colorectal liver metastases. Oncotarget. 2017;8:66117−27. doi.org/10.18632/oncotarget.19806.

  17. Ruers T, Van Coevorden F, Punt CJ, et al. Local treatment of unresectable colorectal liver metastases: Results of a randomized phase II trial. J Natl Cancer Inst. 2017;109. doi: 10.1093/jnci/djx015.

  18. Yamakado K, Inaba Y, Sato Y, et al. Radiofrequency ablation combined with hepatic arterial chemoembolization using degradable starch microsphere mixed with mitomycin C for the treatment of liver metastasis from colorectal cancer: A prospective multicenter study. Cardiovasc Intervent Radiol. 2017;40:560−7. doi: 10.1007/s00270-016-1547-3.

  19. Sasaki K, Margonis GA, Andreatos N,et al. Combined resection and RFA in colorectal liver metastases: stratification of long-term outcomes. J Surg Res. 2016;206:182−9. doi: 10.1016/j.jss.2016.06.098.

  20. Chen Q, Li C, Yang H, Zhao H, et al. Radiofrequency ablation versus resection for resectable liver metastases of gastrointestinal stromal tumours: Results from three national centres in China. Clin Res Hepatol Gastroenterol. 2018; 18: 30228−6. doi: 10.1097/MCG.0000000000000008.

  21. Puijk RS, Ruarus AH, Vroomen LGPH, et al. Colorectal liver metastases: surgery versus thermal ablation (COLLISION) – a phase III single-blind prospective randomized controlled trial. BMC Cancer 2018;18:821. doi: 10.1186/s12885-018-4716-8.

  22. Vogl TJ, Farshid P, Naguib NN, et al. Ablation therapy of hepatocellular carcinoma: a comparative study between radiofrequency and microwave ablation. Abdom Imaging. 2015;40:1829−37. doi: 10.1007/s00261-015-0355-6.

  23. Long L, Wei L, Hong W. Meta-analysis of long-term outcomes in patients with colorectal liver metastases undergoing hepatectomy with or without radiofrequency blation. Am Surg. 2018;84:1913−23.

Labels
Surgery Orthopaedics Trauma surgery
Repopulation of decellularized pig scaffolds: Promising approach for liver tissue engineering
Synchronous liver metastases of rectal cancer and the possibility of simultaneous resection
Jaterní chirurgie 21. století
Therapy of liver cysts – experience of the Department of Surgery, University Hospital in Pilsen 2009−2018
Comparison of surgical intervention to Cyberknife® radiotherapy in the treatment of liver malignancies
Multidisciplinary team in colorectal cancer treatment – analysis of our patients in 2017
Endovascular treatment of aorto-hepatic bypass thrombosis following liver transplantation
Zemřel primář Otomar Rychnovský
Odcházení
Article was published in

Perspectives in Surgery

Issue 10
2019 Issue 10
Most read in this issue
Topics Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#